NYXH - Nyxoah S.A Growth-Adjusted Payback Ratio

Corporate company logo of nyxoah.com (NYXH)

Nyxoah S.A. generates revenue from the sale of implants for the treatment of sleep apnea in patients for whom masks are contraindicated. The growth-adjusted P/E illustrates the market response to this business, where 0.00 expresses the current level of the metric. Growth is driven by the FDA approval of the Genio system, while the strategy relies on the development of B2B distribution channels within US clinics.

Nyxoah S.A (NYXH): Price/Earnings to Growth Ratio from 07/04/2022 to 11/17/2026

Nyxoah S.A. (NYXH) - metric breakdowns and financial figures

- current price and projected stock value:
- market capitalization statistics:
Fundamental company analysis:Nyxoah S.A., NYXH
Core merchandise of Nyxoah S.A

To minimize risk, investors seek assets where the PEG ratio is below one, confirming that the business is undervalued relative to its expansion. By analyzing the P/E ratio relative to EPS growth, one can assess how effectively Nyxoah S.A. (NYXH) monetizes its global presence in the US, Europe, and Australia, converting the international diversification of its implants into accelerated earnings.

Who Nyxoah S.A. competes with

Price/Earnings to Growth Ratio ISRG (Intuitive Surgical)|PEG Multiple DHR (danaher.com)|Growth-Adjusted Market Cap to Net Income bd.com (BDX)|STE - Price/Earnings to Growth Ratio|WST (West Pharma) - Growth-Adjusted P/E Ratio|Baxter Healthcare (BAX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio MASI|Price/Earnings to Growth Ratio stevanatogroup.com|TFX (teleflex.com) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple MMSI (Merit Medical Systems)|Company Value to Earnings Growth Ratio NVST|Price/Earnings to Growth Ratio ICU Medical Corp ICUI|Growth-Adjusted Payback Ratio XRAY|LMAT: Price/Earnings to Growth Multiple|ATRC - PEG Multiple|STAAR Surgical Co. (STAA) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple ChromaDex Corp.|ZIMV (zimvie.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate AngioDynamics Inc. ANGO|Price/Earnings to Growth Ratio Cerus (CERS)|Teknova - Growth-Adjusted P/E Ratio|Monogram Technologies - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio STSS (Sharps Technology, Inc.)|INFU - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income Utah Medical Products UTMD|KORU Medical (KRMD) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Microbot Medical Inc.|Price/Earnings to Growth Ratio Pro-Dex|Price to Earnings Adjusted for Growth Rate Zentek Ltd ZTEK|Price/Earnings to Growth Multiple ELUT (Elutia Inc)|Price/Earnings to Growth Ratio MLSS (Milestone Scientific Corp)|PEG Multiple NXGL (NEXGEL Inc)|PEG Multiple Retractable Tech RVP|Harvard Bioscience Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income Femasys Corp FEMY|MHUA: PEG Multiple|Price/Earnings to Growth Multiple Predictive Oncology|Price/Earnings to Growth Multiple CJMB|ATRI: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple NURO (NeuroMetrix, Inc.)